Compare NWTG & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWTG | ALBT |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 5.9M |
| IPO Year | N/A | 2015 |
| Metric | NWTG | ALBT |
|---|---|---|
| Price | $1.52 | $0.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.3K | ★ 144.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,333,403.00 |
| Revenue This Year | $128.27 | N/A |
| Revenue Next Year | $70.26 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.19 |
| 52 Week Low | $0.82 | $0.51 |
| 52 Week High | $3.50 | $11.66 |
| Indicator | NWTG | ALBT |
|---|---|---|
| Relative Strength Index (RSI) | 49.71 | 41.42 |
| Support Level | $1.34 | $0.51 |
| Resistance Level | $1.54 | $0.93 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 69.91 | 61.60 |
Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.